You are here

Supplements aren't necessarily nutritious: study

New York

NUTRITIONAL supplements and dietary interventions provide little to no protection against cardiovascular disease or death, according to a new review of research published on Monday in the Annals of Internal Medicine. One even showed negative effects.

Lead author Dr Safi U Khan told Bloomberg News that supplement manufacturers have long persuaded consumers to purchase their products with marketing tactics and biased data. "Do not waste your money on these over-the-counter multivitamins and nutritional supplements, because if you are using them with the belief that they are going to reduce your mortality or improve your cardiovascular health, they don't."

The evidence review analysed 16 supplements and eight dietary interventions (such as reduced-saturated-fat diets) from 277 trials of nearly one million people, but calls for further research on the issue. Some results contradicted previous studies, and the confidence level about the conclusions drawn about certain supplement effects is not high.

Not all supplements and diets are worthless, the review found. Folic acid supplements reduce the risk of a stroke, and omega-3 fatty acids were linked to reducing myocardial infraction (MI) and coronary heart disease. A reduction in salt intake, which reduces blood pressure, was found to reduce mortality rates in all patients. Mediterranean and vegetarian diets are listed under US dietary guidelines for healthy eating, but did not have a significant effect on mortality or cardiovascular outcomes in the review of research.

The only supplement to show signs of a negative impact with any sort of confidence was calcium plus vitamin D, which is linked to a greater chance of stroke, according to the study. Other research has associated calcium supplements with an increased risk of MI and death from cancer. The remaining 13 supplements studied showed no benefit or harm.

Supplement use is on the rise in the US, where nearly three out of four people take at least one such product, according to the report. The industry is expected to grow to US$300 billion in the next five years. BLOOMBERG